Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- CheckyesterdayChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing a terminology change from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates.SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov page's footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe error page’s footer revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, with navigation limited to a Home link and revision header. Several study documents and sections (such as PDFs, protocols, and results) appear to have been removed, reducing access to study materials.SummaryDifference21%

- Check50 days agoChange DetectedThe page's core disease references and a related topics/resources section were removed, eliminating explicit mentions of multiple myeloma and genetics-related resources within the study context.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, reflecting a small platform update. This change does not appear to affect study details or user actions.SummaryDifference0.0%

Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.